VOYA Investment Management
OMED

VOYA Investment Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

VOYA Investment Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,652
Closed -$223K – 2729
2015
Q1 		$223K Buy
+8,652
New +$219K ﹤0.01% 2387
2014
Q3 		– Sell
-8,652
Closed -$202K – 2642
2014
Q2 		$202K Buy
+8,652
New +$214K ﹤0.01% 2554

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VOYA Investment Management's OMED Position: Q2 2015 in Review

VOYA Investment Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2015, closing a stake of 8,652 shares — an estimated $223K sold.

VOYA Investment Management first reported a position in OMED in Q2 2014 and held it in 2 quarters. The position peaked at $223K in Q1 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q2 2015.

  • VOYA Investment Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • VOYA Investment Management sold 8,652 OncoMed Pharmaceuticals, Inc. shares in Q2 2015, an estimated $223K.
  • VOYA Investment Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2014 and held it in 2 quarters.
  • VOYA Investment Management's OncoMed Pharmaceuticals, Inc. position peaked at $223K in Q1 2015.
  • 83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2015.

Based on VOYA Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.